$OTIC

Otonomy Inc

NASDAQ
Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing

PRICE

$2.17 ▲2.871%

Last Close

VOLUME

44,878

DAY RANGE

2.06 - 2.2

52 WEEK

1.14 - 2.59

Join Discuss about OTIC with like-minded investors

See 5 more OTIC posts

Key Metrics

Market Cap

122.38 M

Beta

Avg. Volume

166.35 K

Shares Outstanding

56.92 M

Yield

Public Float

Next Earnings Date

2022-08-04

Next Dividend Date

Company Information

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière's disease, hearing loss, and tinnitus.

CEO: David Weber

Website: www.otonomy.com

HQ: 4796 Executive Dr San Diego, 92121-3090 California